Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Puretech Health PLC
Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune

PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune.

It operates through the following segments: Growth Stage Businesses; Project Phase Businesses; and Parent Company and Others.

The Growth Stage Businesses segment focuses on the development on products to solve major healthcare problems in varied markets.

The Project Phase Businesses segment covers the financing, sourcing, and creating new product candidates as well as newly created businesses whose technologies are in the process of validation.

The Parent Company and Others segment involves commences initiatives in themes; raises capital for investment in new companies and existing subsidiaries; and provides other corporate shared services and support for all subsidiaries as well as manages the new company creation process.

The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Number of employees : 145 persons.
Sales per Businesses
20152016Delta
GBP (in Million)%GBP (in Million)%
Growth Stage Programmes6.6786.2%3.0592.9% -54.28%
Project Phase Programmes1.0713.9%0.2487.5% -76.9%
Sales per Regions
20152016Delta
GBP (in Million)%GBP (in Million)%
United States7.6999.3%3.2398.5% -57.92%
Non-United States0.0580.8%0.0641.9% +9.85%
Managers
NameAgeSinceTitle
Daphne Zohar482015Chief Executive Officer & Executive Director
Bharatt M. Chowrira, PhD522017President, Chief Business & Strategy Officer
Joichi Ito51-Non-Executive Chairman
Stephen Muniz--Chief Operations Officer, Secretary & Director
Eric Elenko, PhD--Chief-Research & Strategy
Joseph B. Bolen, PhD642016Chief Scientific Officer
Atul C. Pande, MD632017Chief Medical Officer
Dame Marjorie Morris Scardino712015Senior Independent Non-Executive Director
Bennett M. Shapiro, MD782015Non-Executive Director
Robert S. Langer Jr., DSc682015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 282,429,696 228,337,472 80.8% 0 0.0% 80.8%
Shareholders
NameEquities%
Invesco Asset Management Ltd. 75,964,145 32.0%
Lansdowne Partners (UK) LLP 21,364,916 9.00%
Jupiter Asset Management Ltd. 11,985,304 5.05%
Baillie Gifford & Co. 11,869,398 5.00%
Recordati SpA 9,554,140 4.02%
Daphne Zohar 7,134,094 3.00%
Ruffer LLP 6,000,000 2.53%
Northern Trust Global Investments Ltd. (Securities Lending) 3,218,000 1.36%
Robert S. Langer Jr., DSc 2,944,134 1.24%
David Steinberg, MBA 2,825,000 1.19%
Company contact information
PureTech Health Plc
501 Boylston Street
Suite 6102
Boston, MA 02116

Phone : +1.617.482.2333
Fax : +1.617.482.3337
Web : www.puretechhealth.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PURETECH HEALTH PLC2.67%613
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.75%14 493
NEKTAR THERAPEUTICS44.36%13 873
ALNYLAM PHARMACEUTICALS, INC.-23.27%9 765
SEATTLE GENETICS, INC.-7.14%7 857
QIAGEN6.08%7 574
ALKERMES PLC-15.91%7 186
SAGE THERAPEUTICS INC-10.14%6 776
ICON PLC4.90%6 357
IONIS PHARMACEUTICALS INC-3.56%6 085
EXACT SCIENCES CORPORATION-9.55%5 747
BIO-TECHNE CORP17.93%5 725
PRA HEALTH SCIENCES INC-4.17%5 567
CHARLES RIVER LABORATORIES INTL. INC-3.65%5 057
GALAPAGOS-0.08%4 968
UNITED THERAPEUTICS CORPORATION-22.91%4 932
HANGZHOU TIGERMED CONSULTING CO LTD--.--%4 384
ABLYNX115.64%4 131
Connections : Puretech Health PLC
Tarveda Therapeutics, Inc.
The Carter Center, Inc.
Sigilon Therapeutics, Inc.
Knode, Inc.
Drugs for Neglected Diseases initiative
The Colorado Bar Association
Microchips Biotech, Inc.
Association of Corporate Counsel
Enlight Biosciences LLC
Six Apart KK
London School of Hygiene & Tropical Medicine
Helium Systems, Inc.
Frequency Therapeutics, Inc.
Seventh Sense Biosystems, Inc.
MIT Media Laboratory
Humacyte, Inc.
Culture Convenience Club Co., Ltd.
David H. Koch Institute for Integrative Cancer Research
BI.Garage, Inc.
The Carter Centre United Kingdom
CommenSe, Inc.
American Academy of Arts & Sciences
The Mozilla Foundation
Dickinson College
Silicon Straits Pte Ltd.
Abpro Corp.
littleBits Electronics, Inc.
SQZ Biotechnologies Co.
Oblong Industries, Inc.
XTuit Pharmaceuticals, Inc.
Wearality Corp.
Arsenal Medical, Inc.
IperLane, Inc.
Micell Technologies, Inc.
Thesixtyone, Inc.
Outblaze Ltd.
Noveome Biotherapeutics, Inc.
Sanrio, Inc.
The Water Initiative LLC
Open Source Initiative
98 Whitehall Court LLP
Blind Spot, Inc.
The Carter Centre UK Foundation
Connected Camps
Bridge International Academies Ltd.
Elephant Design Co. Ltd.
Royal Society of Arts
The Momoko Ito Foundation
Libra Biosciences, Inc.
Neoteny 3 LP
Vedanta Biosciences, Inc.
The Japan Society
The Mind & Life Institute
Wikia Japan
TARA Biosystems, Inc.
Technology Review, Inc.
CHS Pharma, Inc.
Massachusetts Institute of Technology
480 Biomedical, Inc.
Karuna Pharmaceuticals, Inc.
Moderna Therapeutics, Inc.
Gelesis Srl
TARIS BioMedical LLC
Gelesis, Inc.
Living Proof, Inc.
Verity BioConsulting LLC
Whitehead Institute for Biomedical Research
Cornell University
Stembiosys, Inc.
Rubius Therapeutics, Inc.
Aris Pharmaceuticals, Inc.
Autifony Therapeutics Ltd.
Lyndra, Inc.
Roivant Sciences GmbH
The Children's Medical Center Corp.
Gecko Biomedical SAS
Golub & Co. LLC
Olivo Laboratories LLC
Verseau Therapeutics, Inc.
Appeering, Inc.
KensaGroup LLC
Royal College of Art
Akili Interactive Labs, Inc.
Mandara Sciences LLC
Arsia Therapeutics, Inc.
Victoria & Albert Museum
Suono Bio, Inc.
© 2018 People , Fundamentals and Ownership